Results 31 to 40 of about 45,160 (301)

Istiglâlu Barâati al-Ikhtirâ’ fî al-Qânûn al-Indûnîsî Dirâsah Fiqhiyah Taqwîmiyah

Al-Ihkam: Jurnal Hukum dan Pranata Sosial, 2020
Patent has a prominent place in people’s nowadays lives as it becomes the main mover of their advancement as well as a barometer of a nation’s development and treasure.
Husnul Haq, Arif Ali Arif
doaj   +1 more source

Why human connection is the true metric of research success

FEBS Open Bio, EarlyView.
Human‐centred mentorship can be shaped by mentor attributes, actions, intrinsic drive and career ambition. Drawing on reflections across Singapore and France, as well as workshop insights from FEBS‐IUBMB ENABLE 2024, this article shows that human‐centred mentorship creates the conditions for sustainable growth, well‐being and retention in research ...
Timothy Lin Yun Tan, Mattias Wei Ren Kon, Xavier Coumoul, Fun Man Fung   +3 more
wiley   +1 more source

U.S. Patent Eligibility Examination Guideline and Practical Issues: Focusing on AI-Related Inventions

Journal of Intellectual Property
This study analyzes the impact and practical implications of the USPTO’s 2024 AI Artificial Intelligence Subject Matter Eligibility Guidance (AI SME).
Sang Ho Lee
doaj   +1 more source

Recent legal developments from a nanotechnology perspective

Nanotechnology Reviews, 2012
With the recent major changes to the patent law system, it is more important than ever for nanotechnology-based companies to reevaluate their patent strategy.
Thiessen Rose, Lozan Vladimir
doaj   +1 more source

Hyperosmotic stress‐induced redistribution of pre‐mRNA cleavage factor I subunits is associated with shifts in alternative polyadenylation

FEBS Open Bio, EarlyView.
Hyperosmotic stress triggers the relocation of the CFIm complex from the nucleus to the cytoplasm. This shift creates a nuclear ‘stoichiometric bottleneck’, limiting CFIm availability for mRNA processing. Consequently, specific mRNAs like NUDT21 and DICER1 undergo targeted 3′UTR shortening, demonstrating how spatial protein dynamics drive rapid ...
Hitomi Soumiya, Masatake Osawa, Hidefumi Fukumitsu   +2 more
wiley   +1 more source

Nanotechnology – New Challenges for Patent Law?

SCRIPTed: A Journal of Law, Technology & Society, 2009
After the advent of IT and genetic engineering, patent law now faces another challenge: nanotechnology. Being a hybrid of chemistry and engineering, nanotechnology holds some peculiarities that cause special problems for patent law.
Herbert Zech
doaj   +1 more source

Legal regulation of gene editing procedure: USA and EU experience

RUDN Journal of Law, 2021
The problem of legal regulation of gene editing in recent years has obviously become global in nature due to the lack of unified systematic legislation in the world.
Elena N. Trikoz, Diana M. Mustafina-Bredikhina, Elena E. Gulyaeva   +2 more
doaj   +1 more source

Brainstem and Cerebellar Volume Loss and Associated Clinical Features in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Progressive Supranuclear Palsy (PSP) is a neurodegenerative ‘tauopathy’ with predominating pathology in the basal ganglia and midbrain. Caudal tau spread frequently implicates the cerebellum; however, the pattern of atrophy remains equivocal.
Chloe Spiegel, Timothy P. Siejka, Cassandra Marotta, Josh J. Y. Lee, Kelly Bertram, Terence J. O'Brien, Meng Law, Lucy Vivash, Ian H. Harding   +8 more
wiley   +1 more source

THE PROTECTION OF TRADITIONAL KNOWLEDGE UNDER INDONESIAN PATENT LAW: BETWEEN OPPORTUNITIES AND CHALLENGES

, 2021
The protection of traditional knowledge through patents is still an interesting issue on an international level. Indonesia revised Patent Law in 2016 (Law Number 13 of 2016 concerning Patent or Indonesian Patent Law).
Yulia, Yulia; Faculty of Law, Malikussaleh University, Indonesia
core   +1 more source

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source